1. Lindquist M. Data quality management in pharmacovigilance. Drug Saf. 2004;27(12):857–70.
2. Stergiopoulos S, Fehrle M, Caubel P, Tan L, Jebson L. Adverse drug reaction case safety practices in large biopharmaceutical organizations from 2007 to 2017: an industry survey. Pharmaceut Med. 2019;33(6):499–510.
3. Bate A, Stegmann JU. Safety of medicines and vaccines—building next generation capability. Trends Pharmacol Sci. 2021;42(12):1051–63.
4. Ghosh R, Kempf D, Pufko A, Barrios Martinez LF, Davis CM, Sethi S. Automation opportunities in pharmacovigilance: an industry survey. Pharmaceut Med. 2020;34(1):7–18.
5. IBM. What is intelligent automation. 2021. https://www.ibm.com/cloud/learn/intelligent-automation